Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.76 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | MIF | P14174 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.58 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11225033 | 0.92 | SLC16A3 (0.72) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL2030497 | 0.89 | SLC16A3 (0.81) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL5467109 | 0.87 | MEN1 (0.69) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL6836135 | 0.87 | SLC16A3 (0.66) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL13432109 | 0.87 | MAOB (0.76) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL24803040 | 0.86 | MAOB (0.71) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL52729 | 0.86 | MAOB (1.00) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL30785604 | 0.86 | MAOB (1.00) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL11097437 | 0.85 | MAOB (0.60) | MAOBSLC16A3ALDH1A1HPGDMIF | |
| SCHEMBL28540565 | 0.85 | SLC16A3 (0.67) | MAOBSLC16A3ALDH1A1HPGDMIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-4289844-A | 3-KETO-COUMARIN DERIVATIVES, HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | claimed |
| US-4278751-A | Photopolymerization co-initiator compositions comprising amine-substituted ketocoumarins and certain acetic acid derivative activators | EASTMAN KODAK COMPANY (US) | 1981-07-14 | — | — | US | claimed |
| EP-0022188-A2 | Co-initiator compositions for photopolymerization containing 3-acyl-substituted coumarins, photopolymerizable composition and photographic element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-01-14 | — | — | EP | claimed |
| US-4147552-A | Light-sensitive compositions with 3-substituted coumarin compounds as spectral sensitizers | EASTMAN KODAK COMPANY (US) | 1979-04-03 | — | — | US | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4555025-B1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B V (NL) | 2026-05-13 | — | — | EP | disclosed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-3902878-B1 | PHOTOINITIATORS | IGM RESINS ITALIA SRL (IT) | 2026-05-06 | — | — | EP | disclosed |
| EP-4736835-A1 | DENTAL POLYMERIZABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-0276016-A2 | Photopolymerizable composition | Nippon Paint Co., Ltd. (JP) | 1988-07-27 | — | — | EP | disclosed |
| US-4366228-A | 3-KETOCOUMARIN DERIVATIVES AS PHOTOSENSITIZERS; ALPHA-PHENYLOXYALKYLENECARBOXYLIC ACIDS AS ACTIVATORS; HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| US-4289844-A | 3-KETO-COUMARIN DERIVATIVES, HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| US-4278751-A | Photopolymerization co-initiator compositions comprising amine-substituted ketocoumarins and certain acetic acid derivative activators | EASTMAN KODAK COMPANY (US) | 1981-07-14 | — | — | US | disclosed |
| EP-0022188-A2 | Co-initiator compositions for photopolymerization containing 3-acyl-substituted coumarins, photopolymerizable composition and photographic element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | MAOB 183/4885SLC16A3 4514/4885ALDH1A1 262/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | MAOB 3945/4885SLC16A3 4091/4885ALDH1A1 668/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | MAOB 506/4885SLC16A3 2817/4885ALDH1A1 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.